IJSTR

International Journal of Scientific & Technology Research

Home About Us Scope Editorial Board Blog/Latest News Contact Us
0.2
2019CiteScore
 
10th percentile
Powered by  Scopus
Scopus coverage:
Nov 2018 to May 2020

CALL FOR PAPERS
AUTHORS
DOWNLOADS
CONTACT

IJSTR >> Volume 2- Issue 10, October 2013 Edition



International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616



Selenium: As A Diagnostic Marker For Malignant Neoplasm

[Full Text]

 

AUTHOR(S)

Asma khan, M. Sc, Muhammad Zafar Iqbal, Ph. D

 

KEYWORDS

Index Terms: Selenium, human blood, malignant neoplasm, trace elements, cancer, Thioredoxins (Trx), selenoprotiens, p53, chemopreventive.

 

ABSTRACT

Abstract: The deficiency of selenium has been correlated with the accelerated development of prostrate cancer in transgenic mice whereas supplementary selenium has been found to reduce progression of lungs cancer in human. This study aims at exploring any association or otherwise of the blood selenium level in cancer patient with the cancer occurrence and the investigation of the selenium as a biomarker for malignancy. The 368 samples were collected including healthy and cancer patients. Results shows that the concentration levels of selenium in the blood of 16 to 70 years males and females both combined together weighted averages for control group are 0.121± 0.03 ug per ml (n= 170). Besides for lungs and breast cancer patients fall in the range of 0.057 ± 0.017 ug per ml (n= 119) and 0.056± 0.018 ug per ml (n= 198) respectively. In cancer patients the selenium levels were significantly lower than in control with a P> 0.05 and critical value are > 0.009 and > 0.01 for lungs and breast cancer patients respectively. Studies also revealed that there is a sharp decline in the blood selenium level of the cancer patients irrespective of the gender, age, and type of cancer as compared to controls.

 

REFERENCES

[1]. Carsten B., Christopher H. L; and Arne H, “ Thiol-based Mechanism Of The Thioredoxin And Glutaredoxin Systems Implications For Disease In The Cardiovascular System.” Am. J. Physiol. Heart Circ. Physiol., 2007, H 1227- H 1236.

[2]. Andoh T. Chock P.B; and Chiueh C. C, “The Role Of Thioredoxine In Protection Against Oxidative Stress Induced Apoptosis In SH- SY5Y Cells.” J. Biol. Chem. 2001, 10: 1074- 1079.

[3]. Ganther H. E, “Selenium Metabolism, Selenoproteins And Mechanisms Of Cancer Prevention; Complexities With Thioredixin Reductase.” Carcinigenesis, 1999, 20 (9): 1657- 1666.

[4]. Jong- Min P., Aeyung K., Jang H. O. and An-sik C, “Methylseleninic Acid Inhibits PMA Stimulated Pro- MMP-2 Activation Mediated By MMT 1-MMP Expression And Further Invasion Through Suppression of Nf-kB Activation.” Carcinogenesis, 2007, 28: 837-847.

[5]. Zeng H ., Anderson M. B., Idso J. P., Hunt C. D, “The Selenium Metabolite Methylselenol Inhibits The Migration And Invasion Potential of HT 1080 Tumor Cells.” The J. Nutri., 2006, 136 no 6. 1528- 1532.

[6]. Fomenko D. E., Xing W., Adair B. M., Thomas D. J., and Gladyshev V. N, “High Through Put Identification Of Catalytic Redox Active Cystein Residues.” Science. 2007, 315(5810): 387- 389.

[7]. Van Cauwenbergh R. ., Deelstra H, Picramenos D; Kostakopoulos A, “Selenium Concentration In Serum Of Healthy Greek Adults.” J Trace Elem. Electrolytes Health Dis. 1994 Jun; 8(2):99-109.

[8]. Liu X. G, “Serum and Tissues Copper, Zinc, And Selenium Levels In Patients With Gastric Carcinoma.,” Zhonghua Zhong Liu Za Zhi, 1991, 13(2): 93- 6.

[9]. Brater P. and Schramel P., “Trace Element Analytical Chemistry In Medicine And Biology.” 1984, 3: 5-9.

[10]. V. Valkovic, V“ Trace Element Analysis” T. W. Bonner Nuclear Laboratories Rice University Houston. Texas and “Ruder Boskovic” Institute Zagreb, Yugoslavia. Taylor & Francis ISBN 0 85066 072 6. TAYLOR & FRANCIS LTD. 10- 14 Maeklin street London WC2B5SNF. Pp. 102

[11]. Saito Y. and Takahashi K., “ Charecterization Of Selenoprotein P As A Selenium Supply Protein”. Eur. J. Biochem., 2002, 269: 5746- 5751.

[12]. Sibichi A. L., Lee J. J., Taylor R. J., et al, “Selenium Accumulation In Prostate Tissue During A Randomized, Controlled Short Term Trial of L- Selenomethionine: A South West Oncology Group Study”. Clin. Cancer Res, 2006, 12: 2178.

[13]. Rayma MP, “Dietary Selenium: Time To Act.” British Medical Journal 1997. 314, 387- 388.

[14]. Rayman M.P, “The Importance Of Selenium To Human Health.” Lancet 2000. 356, 233- 241.

[15]. Rayman M.P, “The Argument For Increasing Selenium Intake.” Proceedings of the Nutrition Society 2002. 61, 203- 215.

[16]. Rayman M.P, “The Use of High Selenium Yeast To Raise Selenium Status: How Does It Measure Up.” British Journal of Nutrition 2004. 92, 557- 573.

[17]. Martin R. Broadley et al, “Biofortification of UK Food Crops With Selenium,” Proceedings of the Nutrition Society. 2006. 65, 169- 181.

[18]. Naseer K., Rehman. S, and Ahmed S,” Determination Of Lead And Cadmium In Milk By Electrothermal Atomic Absorption Spectrophotometry.” Int. J. Environ. Anal. Chem. 1987. 28, Iss 1-2, 132- 141.

[19]. Clinton, O. E, “Determination Of Selenium In Blood And Plant Material By Hydride Generation And Atomic Absorption Spectroscopy”. Analyst 1997, 102: 187- 192.

[20]. Lyengar G. V., “Reference Values for Trace Elements In Human Clinical Specimens: With Special Reference To Biomonitoring and Specimen Suitability”. Biol.Trace element Res. 1987, 12: 263- 295.

[21]. Moreno M. A. Marin C., Vinagre F, Ostapczuk P, ”Trace Element Levels In The Whole Blood Samples From Residents of The City Badajoz. Spain.” The Sci total Environ, 1999, 19; 229(3) 209- 15.

[22]. Morisi G., Patriarca M., Marano G. et Al, “Age and Sex Specific Reference Serum Selenium Levels Estimated for The Italian Population.” Ann. 1st. Super. Sanita., 1989. 25(3); 393- 403.

[23]. Seki H, “Influence of Selenium On Human Health. Part 1” “Sex Difference and Change In Normal Values With Increasing Age.” Nihon Eiseigaku Zasshi. 1987, 42(5): 947- 53.

[24]. Wang YX., Qin J.F., Wu SM., Yan L.B, “Study On The Relation of Se, Mn, Fe, Sr, Pb, Zn, Cu, and Ca To Liver Cancer Mortality From Analysis of Scalp Hair. ”The Sci. Total Environ, 1990, 91: 191- 8.

[25]. Setterdahl A.T. Chivers P.T. Hirasawa M. et al, “Effect of pH On The Oxidation – Reduction Properties of Thioredoxins.” Biochemistry, 2003, 42(50); 14877- 84.

[26]. Nonn L., Williams R.R. Erickson RP., Powis G, “The Absence of Mitochondrial Thioredoxin- 2 Causes Massive Apoptosis, Exencephaly and Early Embryonic Lethality in Homozygous Mice. Mol Cell Biol., 2003, 23(3): 916- 22.

[27]. Powis Gareth and Montfort William R, “Annual Review of Pharmacology and Toxicology.” 2001, 41: 261- 295.

[28]. Patwari P., and Lee R. T, “Thioredoxins, Mitochondria and Hypertension.” Am J Pathol. 2007, 170(3): 805- 8.

[29]. Tao L., Jiao X, Gao E, et al, “Nitrative Inactivation of Thioredoxin-1 and Its Role In Postischemic Myocadial Apoptosis.” Circulation, 2006, 114(13): 1395- 402.

[30]. Schulze P. C., Liu H., Choe E., Yoshioka J., Shalev A., Bloch K. D., Lee R.T, “Nitric Oxide Dependent Suppression of Thiorexin Interacting Protein.” J Bio Chem, 2004, 279: 30369- 74.

[31]. Schrauzer G.N, “Selenium Mechanistic Aspects of Anticarcinogenic Action.” Biol. Trace Elem Res, 1992, 33: 51- 62.

[32]. Gilbert H. F, “Thiole/ Disulfide Exchange Equilibria and Disulfied Bond Theory.” Methods Enzymol., 1995, 251: 8- 28.

[33]. kharitonor V. G., Sundquist A. R., and Sharma V. S. “kinetics of Nitric Oxide Autoxidation In Aqueous Solution.” J Biol Chem. 1994, 269(8) 5881- 5883.

[34]. Cassidy P. B., Edes K., Nelson C.C., Parsawar K. et al, “Thioredoxin Reductase Is Required for The Inactivation of Tumor Suppressor P53 and For Apoptosis Induced By Endogenous Electrophiles.” Carcinogenesis 2006, 27(12): 2538- 49.

[35]. Masaya Ueno., Hiroshi Masutani., Roberto Jun Arai., et al, “Thioredoxin-Dependent Redox Regulation of P53- Mediated P21 Activation.” J Biol Chem., 1999, 274(50): 35809-35815.

[36]. Hansen J. M., Zhang.H., Jones D. P., “Mitochondrial Thioredoxins-2 Has a Key Role In Determining Tumor Necrosis Factor- Alpha- Induced Reactive Oxygen Species Generation, NF- Keppa B activation and Apoptosis” Toxicol Sci 2006, 91(2): 643- 50.